ENV-specific cytotoxic T lymphocyte responses in HIV seronegative health care workers occupationally exposed to HIV-contaminated body fluids - PubMed (original) (raw)

ENV-specific cytotoxic T lymphocyte responses in HIV seronegative health care workers occupationally exposed to HIV-contaminated body fluids

L A Pinto et al. J Clin Invest. 1995 Aug.

Abstract

Identification of the components of protective immunity are crucial for the development of effective prophylactic and therapeutic vaccine strategies. Analysis of HIV-specific responses in exposed but uninfected individuals might thus provide a unique resource to elucidate the components and correlates of protective immunity to HIV. In the present study we analyzed HIV-specific cytotoxic and helper T lymphocyte responses in health care workers (HCW) exposed to body fluids from HIV-positive individuals. HCW exposed to blood from HIV-negative individuals as well as healthy donors served as controls. Cytotoxic T lymphocyte (CTL) responses to HIV envelope (env) peptides were detected in 7/20 (35%) HCW exposed to HIV-positive blood and in none of the 20 health care workers exposed to uninfected blood or the seven healthy blood donors studied. HIV-specific CTL responses were detected only after in vitro stimulation, and were MHC class I restricted. No MHC class I restriction elements were uniformly identified among the different responders. 21/28 (75%) HCW exposed to contaminated blood responded to env as measured by IL-2 production to the peptides, in contrast to only 9/38 (24%) HCW exposed to HIV seronegative blood and 3/35 (9%) healthy blood donors. All the HIV exposed individuals were seronegative on repeated ELISA tests, and no evidence of infection was obtained by PCR analysis. These findings indicate that a single exposure to HIV can induce CTL immunity to HIV antigens, in the absence of other evidence of infection.

PubMed Disclaimer

Similar articles

• Identification of HIV-1 specific T lymphocyte responses in highly exposed persistently seronegative Chinese.
  Liu HW, Hong KX, Ma J, Yuan L, Liu S, Chen JP, Zhang YZ, Ruan YH, Xu JQ, Shao YM. Liu HW, et al. Chin Med J (Engl). 2006 Oct 5;119(19):1616-21. Chin Med J (Engl). 2006. PMID: 17042974
• Evaluation of cytotoxic T cell responses to candidate HIV-1 vaccines in HIV-1-uninfected individuals.
  McElrath MJ, Corey L, Greenberg PD. McElrath MJ, et al. AIDS Res Hum Retroviruses. 1994;10 Suppl 2:S69-72. AIDS Res Hum Retroviruses. 1994. PMID: 7865336 Clinical Trial.
• HIV-specific T-helper activity in seronegative health care workers exposed to contaminated blood.
  Clerici M, Levin JM, Kessler HA, Harris A, Berzofsky JA, Landay AL, Shearer GM. Clerici M, et al. JAMA. 1994 Jan 5;271(1):42-6. JAMA. 1994. PMID: 8258885
• Immune response to human immunodeficiency virus (HIV) in healthcare workers occupationally exposed to HIV-contaminated blood.
  Pinto LA, Landay AL, Berzofsky JA, Kessler HA, Shearer GM. Pinto LA, et al. Am J Med. 1997 May 19;102(5B):21-4. doi: 10.1016/s0002-9343(97)00056-9. Am J Med. 1997. PMID: 9845492 Review.
• Pending problem of "silent" human immunodeficiency virus infection.
  Bentwich Z, Bar-Yehuda S, Nagai K, Wainberg MA, Kalinkovich A, Jehuda-Cohen T. Bentwich Z, et al. Cell Mol Biol (Noisy-le-grand). 1995 May;41(3):345-50. Cell Mol Biol (Noisy-le-grand). 1995. PMID: 7580826 Review.

Cited by

• Polymorphisms in HLA class I genes associated with both favorable prognosis of human immunodeficiency virus (HIV) type 1 infection and positive cytotoxic T-lymphocyte responses to ALVAC-HIV recombinant canarypox vaccines.
  Kaslow RA, Rivers C, Tang J, Bender TJ, Goepfert PA, El Habib R, Weinhold K, Mulligan MJ; NIAID AIDS vaccine evaluation group. Kaslow RA, et al. J Virol. 2001 Sep;75(18):8681-9. doi: 10.1128/jvi.75.18.8681-8689.2001. J Virol. 2001. PMID: 11507213 Free PMC article. Clinical Trial.
• Evidence for persistent, occult infection in neonatal macaques following perinatal transmission of simian-human immunodeficiency virus SF162P3.
  Jayaraman P, Zhu T, Misher L, Mohan D, Kuller L, Polacino P, Richardson BA, Bielefeldt-Ohmann H, Anderson D, Hu SL, Haigwood NL. Jayaraman P, et al. J Virol. 2007 Jan;81(2):822-34. doi: 10.1128/JVI.01759-06. Epub 2006 Nov 1. J Virol. 2007. PMID: 17079310 Free PMC article.
• Cellular immune responses in seronegative sexual contacts of acute hepatitis C patients.
  Kamal SM, Amin A, Madwar M, Graham CS, He Q, Al Tawil A, Rasenack J, Nakano T, Robertson B, Ismail A, Koziel MJ. Kamal SM, et al. J Virol. 2004 Nov;78(22):12252-8. doi: 10.1128/JVI.78.22.12252-12258.2004. J Virol. 2004. PMID: 15507612 Free PMC article.
• Modified vaccinia Ankara expressing HIVA antigen stimulates HIV-1-specific CD8 T cells in ELISpot assays of HIV-1 exposed infants.
  Slyker JA, Lohman BL, Mbori-Ngacha DA, Reilly M, Wee EG, Dong T, McMichael AJ, Rowland-Jones SL, Hanke T, John-Stewart G. Slyker JA, et al. Vaccine. 2005 Sep 7;23(38):4711-9. doi: 10.1016/j.vaccine.2005.01.145. Epub 2005 Feb 19. Vaccine. 2005. PMID: 16043269 Free PMC article.
• Persistently HIV-1 seronegative Nairobi sex workers are susceptible to in vitro infection.
  Bienzle D, Macdonald KS, Copeland KF, Bwayo JJ, Plummer FA, Rosenthal KL. Bienzle D, et al. Can J Infect Dis. 2000 Sep;11(5):259-63. doi: 10.1155/2000/390310. Can J Infect Dis. 2000. PMID: 18159299 Free PMC article.

References

1. 1. Nature. 1987 Jul 23-29;328(6128):345-8 - PubMed
2. 1. AIDS Res Hum Retroviruses. 1992 Aug;8(8):1355-9 - PubMed
3. 1. Science. 1988 Apr 1;240(4848):64-6 - PubMed
4. 1. J Virol. 1993 Feb;67(2):694-702 - PubMed
5. 1. J Exp Med. 1993 Feb 1;177(2):249-56 - PubMed

Publication types

MeSH terms

Substances

LinkOut - more resources

• Full Text Sources

  • American Society for Clinical Investigation
  • Europe PubMed Central
  • Ovid Technologies, Inc.
  • PubMed Central

• Other Literature Sources

  • The Lens - Patent Citations Database

• Medical

  • MedlinePlus Health Information

• Research Materials

  • NCI CPTC Antibody Characterization Program